Proudly Canadian
The Journal
Sermorelin Canada: Research Overview and Sourcing Guide
Sermorelin is one of the older GHRH analogues in the research space and in some ways that’s what makes it interesting. There’s more published literature on it than on newer compounds, which gives researchers a deeper baseline to work from.
Here’s what Canadian researchers need to know.
What is Sermorelin?
Sermorelin is a synthetic peptide that corresponds to the first 29 amino acids of endogenous growth hormone releasing hormone. The full GHRH molecule contains 44 amino acids but research established early on that the first 29 are responsible for the biological activity, making Sermorelin a truncated but functionally active analogue.
It works by binding to the GHRH receptor on pituitary somatotroph cells, stimulating the synthesis and secretion of growth hormone. Like endogenous GHRH, its activity is pulsatile in nature, meaning it produces bursts of growth hormone secretion rather than a sustained elevation.
A pharmaceutical form of Sermorelin was previously approved and used clinically before being discontinued. The research compound version available from Canadian peptide suppliers is not that pharmaceutical product and is intended strictly for in vitro and laboratory research purposes.
Why is Sermorelin still relevant for research?
Given that newer GHRH analogues like CJC-1295 and Tesamorelin have longer half-lives and modified structures, researchers sometimes ask why Sermorelin is still worth studying.
The answer is the literature. Sermorelin has a longer research history than most compounds in the growth hormone space, which means there’s a substantial body of published work researchers can build on. For researchers studying GHRH receptor biology or pituitary function who want to work with a compound that has an established research track record, Sermorelin remains a relevant tool.
Its relatively short half-life, which mirrors endogenous GHRH more closely than modified analogues, is also useful for researchers specifically interested in modeling natural pulsatile GHRH activity rather than sustained receptor stimulation.
How does Sermorelin compare to CJC-1295 and Tesamorelin?
All three are GHRH analogues working through the same receptor pathway but with different structural characteristics that affect their activity profiles.
Sermorelin has the shortest half-life of the three and the most physiologically similar activity pattern to endogenous GHRH. CJC-1295 without DAC is slightly more stable. CJC-1295 with DAC has an extended half-life through albumin binding. Tesamorelin sits in the middle with its trans-3-hexenoic acid modification providing stability without the extended duration of CJC-1295 with DAC.
Choosing between them depends on what your research is designed to measure. If you’re studying pulsatile GHRH signaling, Sermorelin may be the most appropriate tool. If you need sustained receptor activation, one of the modified analogues is more relevant.
Sourcing Sermorelin in Canada
Sermorelin is available from Canadian research peptide suppliers but as with any research compound, quality verification matters.
Independent third-party testing. A batch-specific COA from a named independent laboratory is the standard. Janoshik Analytical is one of the recognized labs in this space. Purity via HPLC and ideally mass spectrometry confirmation are what you’re looking for.
Lot number traceability. The lot number on your vial should match a specific test result you can verify independently.
Clear compound identification. Sermorelin, CJC-1295, and Tesamorelin are all GHRH analogues but they are distinct compounds. Your documentation should clearly identify exactly what you received.
Domestic supply chain. Canadian sourcing eliminates customs risk and keeps your research documentation clean.
Storage and handling
Lyophilized Sermorelin should be stored refrigerated at 2 to 8 degrees Celsius, away from light and moisture. Standard peptide handling protocols apply. Reconstitute with bacteriostatic water, aliquot to avoid repeated freeze-thaw cycles, and use within a reasonable timeframe once in solution.
Common formats
Sermorelin for research is typically supplied as lyophilized powder in sealed glass vials. Common concentrations from Canadian suppliers include 5mg and 10mg vials.
Where BioPerform fits in
BioPerform carries Sermorelin third-party tested by Janoshik Analytical with batch-specific COAs on the product page before purchase. Orders placed before 2PM MST ship same-day from Alberta via Canada Post with tracking confirmation.
Payment is by Interac e-Transfer. Questions about the compound or documentation can be directed to support@bioperform.ca.
All BioPerform compounds are for research purposes only. Not intended for human consumption. For use by licensed researchers in controlled laboratory settings.